A guide on starting, adjusting, and transitioning older adults (65+) from pediatric or young-adult obesity care to liraglutide 3 mg (Saxenda) therapy, with dosing tables, safety data, and evidence-based monitoring protocols.
Saxenda (liraglutide 3 mg) is not FDA-approved for children under 12. This guide explains the current evidence, regulatory status, off-label considerations, and safe injection technique so caregivers can have informed conversations with their child's prescribing physician.
A guide covering how geriatric patients (65+) using spironolactone for acne can safely manage daily activities, physical exertion, hydration, fall risk, and drug interactions.
A guide to spironolactone use for acne in patients aged 65 and older, covering pharmacokinetics, dosing adjustments, drug interactions, hyperkalemia risk, and how adult-care providers should manage this transition.
Review TB-500 evidence for older adults, including the difference from full-length thymosin beta-4 and the limits of dosing, recovery, and safety claims.
A guide to thymosin alpha-1 (thymalfasin) use in adults aged 65 and older, covering community programs, physical activity safety, cognitive engagement, and monitoring protocols specific to the geriatric patient.
A comprehensive clinical review of semaglutide 2.4 mg (Wegovy) use in patients aged 65+, covering efficacy, muscle and bone loss risks, nutritional considerations, dose titration, and updated geriatric prescribing guidance.
A clinically detailed guide to starting, continuing, or transitioning onto Wegovy (semaglutide 2.4 mg) in patients aged 65 and older, covering dosing, safety, muscle loss, polypharmacy, and what geriatric guidelines actually say.
A deep dive into alendronate (Fosamax) hair and skin side effects, including postmarketing case reports, mechanism, and clinical management guidance.
A clinician-level review of alendronate (Fosamax) and its reported effects on mood, depression, anxiety, and cognitive function, with primary-literature citations and a practical monitoring framework.
Fosamax (alendronate) cuts vertebral fracture risk 47% in trials; watch for GI irritation, rare jaw issues, and femur fracture risk after 5+ years of use.
A clinician-level review of alendronate (Fosamax) and the kidneys: pharmacokinetics, renal clearance, CKD dosing thresholds, evidence from FIT and post-market data, and practical monitoring guidance.
A guide to alendronate (Fosamax) storage conditions, shelf-life data, stability science, and what degradation means for fracture-risk protection.
Evidence-based guidance on when to pause alirocumab (Praluent) before surgery, covering pharmacokinetics, bleeding risk, lipid rebound, and restart timing for cardiovascular patients.
A guide to alprostadil safety in men aged 30 to 49, covering injection-site reactions, priapism risk, contraindications, dosing protocols, and how intracavernosal versus intraurethral delivery compare on the safety profile.
A clinician-level review of alprostadil's emerging delivery systems, combination approaches, and pipeline agents targeting refractory erectile dysfunction beyond the current intracavernosal and intraurethral formulations.
Step-by-step alprostadil intracavernosal injection and MUSE urethral suppository technique, with dosing, mechanism, safety data from Linet et al. (NEJM 1996), and guidance for men with refractory erectile dysfunction.
A clinical deep-dive into how amlodipine, a calcium channel blocker used for hypertension and angina, affects bone mineral density, fracture risk, osteoclast activity, and long-term skeletal outcomes, with primary-literature citations.
A clinician-level review of amlodipine's impact on cognitive function, covering ASCOT-BPLA, calcium-channel mechanisms, blood-pressure lowering effects on dementia risk, and practical prescribing guidance.
A deep dive into how amlodipine affects liver enzymes, hepatic metabolism, and safety in patients with liver disease. Includes primary-literature citations, dosing guidance, and clinical decision frameworks.
Amlodipine monitoring requires no routine labs in most patients: check blood pressure, heart rate and ankle edema at 2-4 weeks, then every 3-6 months.
A guide to amlodipine safety in adults aged 50, 64, covering cardiovascular benefits, side-effect profile, drug interactions, perimenopause/andropause overlap, and practical dosing guidance backed by named trials and guidelines.
Evidence-based guidance on whether to hold or continue amlodipine before surgery, covering hemodynamic risks, guideline recommendations, anesthetic interactions, and clinical decision frameworks for perioperative management.
A clinician-level review of how amlodipine affects sleep stages, nocturnal blood pressure, and polysomnography findings, with primary-literature citations and practical prescribing guidance.
A detailed guide to Aetna (CVS Health) AndroGel coverage, prior authorization criteria, step therapy requirements, formulary tier placement, and how to appeal a denial.
A guide to AndroGel (testosterone gel 1% and 1.62%) safety in men aged 65 and older, covering cardiovascular risk, falls, polypharmacy, renal considerations, and when deprescribing makes sense.
A guide to Humana coverage of AndroGel (testosterone gel 1% and 1.62%), including formulary tiers, prior authorization criteria, step therapy requirements, and how to appeal a denial.
A guide to AndroGel (testosterone gel 1% and 1.62%) safety for men ages 50 to 64, covering cardiovascular risk, prostate monitoring, polypharmacy, dosing, and what the T-Trials data actually show.
Stopping AndroGel triggers predictable hormonal rebound effects including suppressed LH, FSH, and endogenous testosterone. Learn what the clinical evidence says, how long recovery takes, and what your doctor can prescribe to speed restoration.
How to time AndroGel application across time zones, store testosterone gel safely while traveling, and maintain stable serum testosterone levels during long-haul trips. Reviewed by HealthRX.com physicians.
A complete guide to TRICARE coverage for AndroGel (testosterone gel 1%/1.62%), including formulary tier, prior authorization criteria, step therapy requirements, and how to appeal a denial.
A guide to AndroGel (testosterone gel) safety for men aged 18, 29, covering fertility, bone health, cardiovascular risk, dosing, and monitoring protocols based on current evidence.
A guide to the complete AOD-9604 monitoring schedule, including baseline labs, on-therapy exams, safety biomarkers, and when to adjust or stop treatment.
A breakdown of every documented off-label use of AOD-9604 (HGH fragment 176-191), graded by evidence level, with PubMed and FDA citations.
A guide to stopping Armour Thyroid (natural desiccated thyroid) safely, including tapering schedules, symptom monitoring, TSH targets, and when an abrupt stop is medically justified.
A guide to every food, mineral, fiber, and supplement that blocks or alters Armour Thyroid (natural desiccated thyroid) absorption and hormone levels, with dosing windows, lab targets, and management strategies.
A deep-dive into how Armour Thyroid (natural desiccated thyroid) affects liver function tests, including ALT, AST, and alkaline phosphatase, with primary-literature citations and clinical dosing guidance.
An evidence-based guide to how atorvastatin (Lipitor) affects appetite and food cravings, covering pharmacology, clinical trial data, real-world reports, and what to do if your hunger changes on a statin.
Atorvastatin's FDA label notes rare, reversible memory complaints, but large trials like ASCOT-LLA show no significant cognitive harm at the population level.
A clinical week-by-week guide to atorvastatin's first 30 days: when LDL drops, what side effects emerge, and exactly what lab values to monitor.
A guide to atorvastatin (Lipitor) food and supplement interactions, covering grapefruit, red yeast rice, CoQ10, omega-3s, St. John's wort, and more, with PubMed-cited evidence and practical dosing guidance.
A guide to atorvastatin (Lipitor) hair loss, skin rashes, and dermatologic side effects, with primary-literature citations and clinical management guidance.
Anadrol is an FDA-approved oral steroid for anemia, used off-label for mass gain. Learn its dosing, potency, and serious liver and heart risks.
A clinical comparison of Anavar (oxandrolone) vs Ostarine (MK-2866): mechanisms, body-composition data, side-effect profiles, legality, and which option fits your goals.
A guide to cachexia covering diagnostic criteria, muscle-wasting mechanisms, drug therapies, nutrition protocols, and how cachexia differs from sarcopenia and simple malnutrition.
Clenbuterol causes arrhythmias, hypertension, and structural heart damage even at low doses. SARMs carry measurable liver toxicity and suppress the HPG axis in weeks. This clinical review covers mechanisms, documented cases, and safer alternatives.
Anavar (oxandrolone) has a milder side-effect profile than most anabolic steroids, but 'safer' is relative. This evidence-based guide compares hepatotoxicity, cardiovascular risk, androgen suppression, and legal status across oxandrolone, testosterone, nandrolone, and SARMs.
A guide to L-carnitine injections covering mechanism, clinical evidence, dosing protocols, comparisons with SARMs like RAD-140 and LGD-4033, and who is a candidate for injectable carnitine therapy.
Off-label ostarine cycles run 10-25 mg daily for 6 to 8 weeks, above the 1-3 mg used in trials. No dose is FDA-approved and testosterone drops are common.
Ostarine (MK-2866) is an investigational SARM, not FDA-approved. Phase II trials showed a 1.4 kg lean mass gain at 3 mg/day; WADA bans all SARMs in sport.
A head-to-head clinical comparison of ostarine (MK-2866) and LGD-4033 (ligandrol): muscle gain, fat loss, suppression, side effects, and why neither is FDA-approved.
A guide to post-cycle therapy after SARMs, covering which SARMs suppress the HPG axis, when PCT is necessary, clomiphene and nolvadex dosing, and how to confirm recovery with bloodwork.
A guide to optimizing body composition after bariatric surgery, covering protein targets, resistance training, hormonal changes, and evidence-based strategies for athletes, older adults, and women.
A detailed breakdown of RAD-140 (testolone), covering its mechanism, clinical evidence, side effects, legal status, and how it compares to ostarine, LGD-4033, cardarine, and SR9009.
A comparison of SARMs and anabolic steroids covering mechanism, efficacy, side-effect profiles, legality, and how specific compounds like ostarine, LGD-4033, and oxandrolone stack up on current evidence.
Visceral fat surrounds your organs, drives metabolic disease, and resists ordinary dieting. Learn what research says about measuring it, losing it, and why GLP-1s, strength training, and sleep matter more than crunches.
A guide to body recomposition timelines: how long fat loss and muscle gain take simultaneously, what the research says, and when to consider hormonal support.
SARMs can be detected on specialized sports anti-doping panels but are missed by standard workplace urine screens. Learn which tests catch them, how long they stay in your system, and what the legal and health risks really are.
A breakdown of YK-11, covering its mechanism, the limited human safety data, legal status, and how it compares to ostarine, LGD-4033, RAD-140, and cardarine.
Find out whether Aetna covers Prolia (denosumab) for osteoporosis, what prior authorization requirements apply, how much you might pay out of pocket, and what to do if your claim is denied.